Science Update: Biomarker for Niemann-Pick type C may be useful for diagnosing other class of rare disorders, NIH study suggests
Por um escritor misterioso
Descrição
A biomarker used to detect a rare neurodegenerative disorder of cholesterol metabolism, Niemann-Pick disease type C1 (NPC1), may also be useful for diagnosing another class of rare diseases known as congenital disorders of glycosylation (CDG), suggests a study by researchers at the National Institutes of Health.

Identification of cerebral spinal fluid protein biomarkers in Niemann-Pick disease, type C1, Biomarker Research

At a glance: the largest Niemann-Pick type C1 cohort with 602 patients diagnosed over 15 years

IJMS, Free Full-Text

Efficacy and safety of arimoclomol in Niemann‐Pick disease type C: Results from a double‐blind, randomised, placebo‐controlled, multinational phase 2/3 trial of a novel treatment - Mengel - 2021 - Journal of Inherited

Improved systemic AAV gene therapy with a neurotrophic capsid in Niemann–Pick disease type C1 mice

PDF) Laboratory diagnosis of the Niemann-Pick type C disease: an inherited neurodegenerative disorder of cholesterol metabolism

Identification of Niemann-Pick C1 disease biomarkers through sphingolipid profiling - ScienceDirect

Clinical disease progression and biomarkers in Niemann–Pick disease type C: a prospective cohort study, Orphanet Journal of Rare Diseases
Niemann Pick Disease Type C - Symptoms, Causes, Treatment

Niemann-Pick disease type C, Orphanet Journal of Rare Diseases

At a glance: the largest Niemann-Pick type C1 cohort with 602 patients diagnosed over 15 years
de
por adulto (o preço varia de acordo com o tamanho do grupo)